-
公开(公告)号：US20220378363A1
公开(公告)日：2022-12-01
申请号：US17730075
申请日：2022-04-26
申请人： Massachusetts Institute of Technology , Trustees of Boston University , The Brigham and Women's Hospital, Inc.
发明人： Timothy Kuan-Ta Lu , Rabia Tugce Yazicigil Kirby , Carlo Giovanni Traverso , Jenna Ahn , Maria Eugenia Inda , Miguel Jimenez , Qijun Liu , Phillip Nadeau , Christoph Winfried Johannes Steiger , Adam Wentworth
IPC分类号： A61B5/00 , C12Q1/6897 , A61B5/145 , A61B5/1459
摘要： Transient molecules in the gastrointestinal (GI) tract, such as nitric oxide and hydrogen sulfide, are important signals and mediators of inflammatory bowel disease (IBD). Because these molecules may be short-lived in the body, they are difficult to detect. To track these reactive molecules in the GI tract, a miniaturized device has been developed that integrates genetically engineered probiotic biosensors with a custom-designed photodetector and readout chip. Leveraging the molecular specificity of living sensors, bacteria were genetically encoded to respond to IBD-associated molecules by luminescing. Low-power electronic readout circuits (e.g., using nanowatt power) integrated into the device convert the light from just 1 μL of bacterial culture into a wireless signal. Biosensor monitoring was demonstrated in the GI tract of small and large animal models and integration of all components into a sub-1.4 cm3 ingestible form factor capable of supporting wireless communication. The wireless detection of short-lived, disease-associated molecules may support earlier diagnosis of disease than is currently possible, more accurate tracking of disease progression, and more timely communication between patient and their care team supporting remote personalized care.
-
公开(公告)号：US20230398067A1
公开(公告)日：2023-12-14
申请号：US18035969
申请日：2021-11-10
CPC分类号： A61K9/0065 , A61K38/465 , A61K47/24 , A61K38/4826 , A61K38/443 , A61K38/47 , A61K38/28 , C12Y304/21004 , C12Y101/03004 , C12Y302/01108
摘要： Articles and methods related to the administration of biomolecules to subjects using metal-organic frameworks are generally described. In some embodiments, an article is described, the article comprising a substrate comprising an adhesive layer, a support layer disposed on at least a portion of the substrate, and an active material disposed on and/or in at least a portion of the support layer, wherein the active material comprises a composite comprising a metal-organic framework and a biomolecule. In certain embodiments, a method of treating a subject with a biomolecule is described, the method comprising administering an article to a subject.
-
公开(公告)号：US20230001083A1
公开(公告)日：2023-01-05
申请号：US17782973
申请日：2020-12-04
发明人： Carlo Giovanni Traverso , Jason Siu-Wei Li , Rebecca McManus , Seungho Lee , Adam Wentworth , Qianqian Wan
摘要： Delivery systems and their methods of use for delivering one or more therapeutic compounds to a user are described. A delivery system may include an implantable pump and an external actuator. The implantable pump may include an actuatable portion that may be actuated to dispense a volume of fluid. The external actuator may include a pusher configured to deform skin to engage an actuatable portion of the pump. The external actuator may also include a positioning magnet configured to magnetically attract a portion of the implantable pump such that the external actuator and the pump may be aligned prior to applying force to the portion of the skin between the external actuator and the actuatable portion of the pump.
-
-
搜索结果
3 条记录 (耗时 0.023 秒)
